Affiliation:
1. State Key Laboratory of Metastable Materials Science and Technology Nano‐Biotechnology Key Lab of Hebei Province Applying Chemistry Key Lab of Hebei Province Heavy Metal Deep‐Remediation in Water and Resource Reuse Key Lab of Hebei Yanshan University Qinhuangdao 066004 China
2. Department of Prosthodontics Shanghai Ninth People's Hospital Shanghai Jiao Tong University School of Medicine College of Stomatology Shanghai Jiao Tong University National Center for Stomatology National Clinical Research Center for Oral Diseases Shanghai Key Laboratory of Stomatology Shanghai Research Institute of Stomatology Shanghai Engineering Research Center of Advanced Dental Technology and Materials Shanghai 200011 China
3. School of Physics and Information Technology Shaanxi Normal University Xi'an 710062 China
Abstract
AbstractIn oncological nanomedicine, overcoming the dual‐phase high interstitial pressure in the tumor microenvironment is pivotal for enhancing the penetration and efficacy of nanotherapeutics. The elevated tumor interstitial solid pressure (TISP) is largely attributed to the overaccumulation of collagen in the extracellular matrix, while the increased tumor interstitial fluid pressure (TIFP) stems from the accumulation of fluid due to the aberrant vascular architecture. In this context, metal–organic frameworks (MOFs) with catalytic efficiency have shown potential in degrading tumor interstitial components, thereby reducing interstitial pressure. However, the potential biotoxicity of the organic components of MOFs limits their clinical translation. To circumvent this, a MOF‐like photocatalytic nanozyme, RPC@M, using naturally derived cobalt phytate (CoPA) and resveratrol (Res) is developed. This nanozyme not only facilitates the decomposition of water in the tumor interstitium under photoactivation to reduce TIFP, but also generates an abundance of reactive oxygen species through its peroxidase‐like activity to exert cytotoxic effects on tumor cells. Moreover, Res contributes to the reduction of collagen deposition, thereby lowering TISP. The concurrent diminution of both TISP and TIFP by RPC@M leads to enhanced tumor penetration and potent antitumor activity, presenting an innovative approach in constructing tumor therapeutic nanozymes from natural products.
Funder
Natural Science Foundation of Hebei Province
National Natural Science Foundation of China